Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

Allogeneic stem cell transplantation (SCT) from an HLA-haploidentical relative provides a potentially curative treatment option for hematologic malignancies patients who lack a suitably HLA-matched donor. The greatest challenge to performing HLA-haploidentical SCT has been high rates of graft failur...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Munchel, Ashley, Kesserwan, Chimen, Symons, Heather J., Luznik, Leo, Kasamon, Yvette L., Jones, Richard J., Fuchs, Ephraim J.
Formato: Artigo
Idioma:Inglês
Publicado: PAGEPress Publications 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206539/
https://ncbi.nlm.nih.gov/pubmed/22053277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/pr.2011.s2.e15
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares